Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No significant differences were observed regarding sex, smoking status, total cholesterol, and 25-hydroxyvitamin D (all P > .05).
Source: 3.1. Baseline characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Rheumatoid arthritis was determined through self-reported responses based on an interview, with similar efficiency compared to clinical assessments confirmed by previous investigations.[,] Participants were first asked whether they had ever been diagnosed with any form of arthritis by a healthcare professional.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Sarcopenia, an independent predictor for all-cause mortality in rheumatoid arthritis: Insights from the NHANES database
Study design awaiting verification · Medicine · 2026
Original publication title
Sarcopenia, an independent predictor for all-cause mortality in rheumatoid arthritis: Insights from the NHANES database
Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Sarcopenia, characterized by a decline in muscle mass and function, is increasingly recognized as a significant comorbidity in chronic diseases, including rheumatoid arthritis (RA). However, its relevance to all-cause mortality in RA patients remains to be explored. Here, we examine the correlation between sarcopenia and all-cause mortality in RA patients using the NHANES database. Data were obtained from 910 RA patients identified through self-reported data in the nationwide NHANES (1999 to 2018). Sarcopenia was defined by an appendicular skeletal muscle mass index adjusted for body mass index (ASM/BMI).
Cox regression models were utilized to measure the connection between sarcopenia and all-cause mortality, adjusted for demographic, clinical, and lifestyle factors. Moreover, subgroup and sensitivity analyses were also performed. Sarcopenia was independently linked to a higher risk of all-cause mortality (HR = 1.610, 95% CI: 1.192 to 2.176, P = .002) after adjusting for potential confounders. Subgroup analysis showed significant associations in individuals aged <60 years, males, and those with comorbid conditions such as hypertension, diabetes, and cardiovascular disease. Additionally, sensitivity analysis confirmed the robustness of the findings.
Sarcopenia was associated with a higher mortality risk in patients with RA, suggesting that its early identification and management may improve survival outcomes.
Authors’ abstract
Sarcopenia, characterized by a decline in muscle mass and function, is increasingly recognized as a significant comorbidity in chronic diseases, including rheumatoid arthritis (RA). However, its relevance to all-cause mortality in RA patients remains to be explored. Here, we examine the correlation between sarcopenia and all-cause mortality in RA patients using the NHANES database. Data were obtained from 910 RA patients identified through self-reported data in the nationwide NHANES (1999 to 2018). Sarcopenia was defined by an appendicular skeletal muscle mass index adjusted for body mass index (ASM/BMI).
Cox regression models were utilized to measure the connection between sarcopenia and all-cause mortality, adjusted for demographic, clinical, and lifestyle factors. Moreover, subgroup and sensitivity analyses were also performed. Sarcopenia was independently linked to a higher risk of all-cause mortality (HR = 1.610, 95% CI: 1.192 to 2.176, P = .002) after adjusting for potential confounders. Subgroup analysis showed significant associations in individuals aged <60 years, males, and those with comorbid conditions such as hypertension, diabetes, and cardiovascular disease. Additionally, sensitivity analysis confirmed the robustness of the findings.
Sarcopenia was associated with a higher mortality risk in patients with RA, suggesting that its early identification and management may improve survival outcomes.
Publication and source details
Original title: Sarcopenia, an independent predictor for all-cause mortality in rheumatoid arthritis: Insights from the NHANES database
Xiaodong Zhang; Hua Liu; Tianzuo Lan; Xin Cai
Medicine · 2026
* Correspondence: Xin Cai, Department of Rheumatology and Immunology, The First People’s Hospital of Guiyang, No. 97 Bo’ai Road, Nanming District, Guiyang 550002, Guizhou, China (e-mail: sylvan25@163.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:11:33.082909+00:00
DOI: 10.1097/md.0000000000050000 · PMC13433025